RemeGen’s China Clinical Win In gMG Paves Way For Global Phase III

 
• By Dexter Jie Yan
  
Concept of Myasthenia Gravis written on sticky notes isolated on Wooden Table.
Telitacicept's domestic clinical win expected to accelerate global Phase III program for gMG • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia